<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Activation of <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptors and alpha-amino-3-hydroxy-5-<z:chebi fb="36" ids="29309">methyl</z:chebi>-4-<z:chebi fb="0" ids="35595">isoxazole</z:chebi>-<z:chebi fb="0" ids="30768">propionic acid</z:chebi> (AMPA) receptors play an important role in the neurons <z:hpo ids='HP_0011420'>death</z:hpo> induced by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The mitigating effect of <z:chebi fb="1" ids="38877">intravenous anesthetics</z:chebi> on ischemic neuron injury is related to their influence on <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors </plain></SENT>
<SENT sid="2" pm="."><plain>This study was performed to investigate the effect of ketamine-midazolam anesthesia on the <z:chebi fb="0" ids="31882">NMDA</z:chebi> and AMPA receptor subunits expression in the peri-infarction of ischemic rat brain and explore its potential mechanism of neuroprotection </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Thirty Sprague Dawley (SD) rats were subjected to permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> under ketamine/<z:chebi fb="28" ids="16684">atropine</z:chebi> (100/0.05 mg/kg) or ketamine-midazolam/<z:chebi fb="28" ids="16684">atropine</z:chebi> (60/50/0.05 mg/kg) intraperitoneal anesthesia (n=15 each) </plain></SENT>
<SENT sid="4" pm="."><plain>Twenty-four hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, five rats in each group were killed by injecting the above dosage of ketamine or ketamine-midazolam intraperitoneally and <z:mpath ids='MPATH_124'>infarct</z:mpath> size was measured </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-four and 72 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, four rats in each group were killed by injecting the above dosage of ketamine or ketamine-midazolam intraperitoneally </plain></SENT>
<SENT sid="6" pm="."><plain>After staining the brain tissue slices with toluidine blue, the survived neurons in the peri-infarction were observed </plain></SENT>
<SENT sid="7" pm="."><plain>Also, the expression level of <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors 1 (NR1), <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors 2A (NR2A), <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors 2B (NR2B) and AMPA (GluR1 subunit) were determined by grayscale analysis in immunohistochemical stained slices </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Compared with ketamine anesthesia, ketamine-midazolam anesthesia produced not only smaller <z:mpath ids='MPATH_124'>infarct</z:mpath> size [(24.1+/-4.6)% vs (38.4+/-4.2)%, P&lt;0.05], but also higher neuron density (24 hours: 846+/-16 vs 756+/-24, P&lt;0.05; 72 hours: 882+/-22 vs 785+/-18, P&lt;0.05) and lower NR2A (24 hours: 123.0+/-4.9 vs 95.0+/-2.5, P&lt;0.05; 72 hours: 77.8+/-4.1 vs 54.2+/-3.9, P&lt;0.05) and NR2B (24 hours: 98.5+/-2.7 vs 76.3+/-2.4, P&lt;0.05; 72 hours: 67.2 +/-7.5 vs 22.2+/-2.6, P&lt;0.05) expression level in the peri-infarction following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The protective effects of ketamine-midazolam anesthesia on ischemic brain injury may related to decreasing NR2A and NR2B expression </plain></SENT>
</text></document>